Researchers Flip Pharmaceutical AI to Create 40,000 Biowarfare Agents

Audrey Carleton

Machine learning has offered the pharmaceutical industry a lot. It automated the drug discovery process, making it easier to identify proteins that indicate disease, predicting molecules that will effectively bind to them to treat it, and shortened the process by which essential medicines—like COVID-19 vaccines—get rolled out.

Machine learning has also made it easier to make bioweapons at scale using these same tools, a group of researchers warned in the journal Nature Machine Intelligence this month. In the paper, the authors trained a drug development tool to identify  40,000 potential bioweapons in just six hours.

Latest articles

Byram W. Bridle … In response to a great question about a...
Vesanto Melina Soy has been the focus of considerable controversy. The roots...
Mark Messina … Isoflavones are classified as both phytoestrogens and selective estrogen...
BRMI … The lymphatic system lacks an organ that acts as a...
Jiacheng Huang et al. The extracellular matrix (ECM) is one of the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!